Released May 6, 2022, before the open
10-Q filed May 6, 2022, 36 days after period end · 0000950170-22-007997
Q1 2022 · 10-Q
Revenue$106.42M$106.42M +0.8% vs Q1 2021−14.9% vs Q4 2021
Net Income-$4.46M-$4.46M N/M vs Q1 2021N/M vs Q4 2021
EPS Diluted-$0.22-$0.22 N/M vs Q1 2021no prior Q4 2021 on file
Gross Profit$78,100,000−2.0%
Operating Income-$3,078,000N/M
Operating Cash Flow-$7,709,000N/M
Free Cash Flowderived-$13,038,000N/M
Margins · derived
Gross margin73.4%−2.1 pt vs Q1 2021
Operating margin-2.9%−0.1 pt vs Q1 2021
Net margin-4.2%+1.3 pt vs Q1 2021
What the release said
The release
Same quarter
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $106.42M | $105.59M | $104.82M | $109.11M |
| Net Income | -$4.46M | -$5.82M | $25.67M | $897.00K |
| EPS Diluted | -$0.22 | -$0.30 | $1.32 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR